Background: See-and-treat (S&T), renowned for success in gynaecology, are gaining traction in plastic surgery, especially for managing non-melanoma skin cancers. The upsurge in skin cancer referrals challenges Australia's public healthcare system, impacting plastic surgery units' efficiency and escalating patient wait times. This study investigates the feasibility of S&T as an alternative to traditional operating theatre (OT) resections for skin cancer. Aims and Hypothesis: To analyse published outcomes of skin cancer resection in S&T clinics versus traditional OT. We hypothesize that S&T is a viable alternative, offering reduced waiting times and comparable surgical and oncological outcomes. Search Strategy: Employing PRISMA guidelines, a comprehensive search strategy across major databases focused on adult patients with cutaneous malignancy, comparing surgical resection locations and evaluating outcomes. Results: Qualitative synthesis of 4 studies indicates significant reductions in wait times with S&T, maintaining oncological outcomes. Patient satisfaction consistently exceeds traditional methods, indicating enhanced access to care. Studies lack comprehensive data on complications and surgical outcomes. Discussion: While S&T exhibits clear benefits, the absence of complication rates and patient selection criteria limits a holistic understanding. Conclusion: S&T emerges as a promising model for expedited skin cancer care, reducing surgical wait times while maintaining high excision standards. Further large cohort studies are vital to comprehensively evaluate outcomes and understand broader implications for healthcare systems. Expanding S&T utilization could significantly benefit skin cancer patients.